Last month, leadership of the American Medical Association, in conjunction with representatives from medical schools in Pennsylvania and Rhode Island, unveiled the latest innovation in the quest to improve physician training to meet the demands of practicing medicine in the 21st century.
Rotator cuff surgery, once a subspecialty with a low public profile, has become the subject of frequent headlines for sports fans. And a new generation of technology is improving surgical outcomes as well as the recovery process. The increased visibility of rotator cuff surgery results from several factors according to Kenneth Bramlett, MD of the Orthopaedic Sports Medicine Clinic of Alabama.
With the belief that suicide deaths for individuals under the care of a provider should be preventable, behavioral health specialists have set a goal that is both audacious and aspirational.
There's one provision of the Affordable Care Act that hasn't gotten much attention outside the industry, but it's a significant one: providers face financial penalties when a patient is readmitted more than 30 days after treatment.
With the launch of trials.cancer.gov, the National Cancer Institute hopes that making clinical trial information more user-friendly will result in greater awareness and participation in clinical trials to move the science forward faster.
Many of us experience leg discomfort, especially at the end of the day. However, there are a number of symptoms that can point to the possibility that someone has chronic venous insufficiency: heaviness, aching, swelling throbbing, itching, and/or cramping in your legs.
A professor in the UAB School of Health Professions and Vice-Chair for Research in the Department of Nutrition Sciences, Barbara Gower, PhD, serves as director of the metabolism core for the Nutrition Obesity Research Center and is a senior scientist at the UAB Comprehensive Cancer Center.
Using the Body's Own Defenses to Fight Cancer
This summer the American Society for Clinical Oncology (ASCO) conference in Chicago named immunotherapy its Advance of the Year for 2016. This approach to treatment is being called possibly an even greater breakthrough than chemotherapy.
One in seven men in the United States will face prostate cancer at some time in their lives, making the disease the second leading cause of cancer death in America. For some of these patients, a new minimally invasive procedure can help them avoid surgery and the side effects that may follow.
There's something missing in Dr. Macy Smith's cardiac operating room these days: the use of a bulky fluoroscope, and the collection of leaded aprons needed to protect doctors, staff, and patients from the machine's continuous X-rays.
During a man's lifetime, odds are one in seven that he be diagnosed with prostate cancer. If it's a slower growing form detected in later years, he may live out a normal life span and die with it, but not from it.
More than half of men 50 years of age and older, and up to 90 percent of men over 80 are affected by symptoms of benign prostatic hyperplasia BPH, or enlarged prostate, which can significantly impact quality of life.
For most physicians, difficult conversations come with the territory.
After the initial shock of hearing a serious diagnosis and absorbing what the prognosis could mean, the next question patients often ask is why. Why me? Why now?
The landmark Alzheimer's Disease Neuroimaging Initiative (ADNI) began in October 2004 with a goal of finding more sensitive and accurate methods to detect Alzheimer's disease (AD) in the early stages and to track progression by identifying and monitoring biomarkers. Last month, the NIH's National Institute on Aging announced an award of approximately $40 million over the next five years to launch ADNI3.
Almost half of women in the United States suffer from symptoms of declining estrogen, including the uncomfortable condition of vaginal atrophy. The atrophy causes thinning, drying and inflammation of the vaginal walls which leads to painful intercourse and problems with urination.
For patients with advanced stage cancer, time is life.
HudsonAlpha Institute for Biotechnology has joined 13 of the nation's top cancer research centers in the Oncology Research Information Exchange Network® (ORIEN), a collaboration to accelerate clinical development and discovery of treatments for advanced-stage cancers.
A wave of excitement swept through medical science in 2003 when the first sequencing of the human genome was completed. News stories were full of enthusiastic predictions of a revolution in health care.
Cardiologists at UAB Hospital are the first in Alabama to treat coronary artery disease patients with a new dissolving heart stent. The Abbott's Absorb bioresorbable vascular scaffold (BVS), FDA approved for use in July, gradually dissolves and may be a safer option for patients in the future.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: